News at CenExel

CenExel Acquires California Neuroscience Research

Salt Lake City, January 10, 2022 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of California Neuroscience Research (“CenExel CNR”), a clinical research facility in Los Angeles with two decades of experience in neurological...

Opioid Use Disorder Clinical Trial Methodologies

CenExel is proud to highlight the poster presented at the Annual International/Canadian Society of Addiction Medicine, November 2020, Virtual Meeting. ABSTRACT Introduction: The need to conduct clinical trials for the treatment of opioid use disorder (OUD) cannot be...

PCRS in Depression Clinical Trials

CenExel is proud to highlight the poster presented at the Annual International Society for CNS Clinical Trials and Methodology (ISCTM) Meeting, February 2019, Washington, DC. ABSTRACT Introduction: Although the placebo effect continues to persist within depressive...